Implications of Cannabis Rescheduling

Dear Client: At the end of April, reports surfaced that the US Drug Enforcement Administration (DEA) will reclassify cannabis from a Schedule I to a Schedule III drug [see WSD 04-30-2024]. Shortly after that report, the US Attorney General confirmed the proposal to reclassify cannabis. You'll recall, as a Schedule III drug, cannabis would be considered along the same lines as ketamine and some anabolic steroids; it's currently a Schedule I drug alongside heroin and LSD, among others.  While there